Should You Get a Blood Test For Alzheime...

In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ... Show More

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ... Show More

In this episode, host Rachel Feltman interviews neuroscientist Kauê M. Costa, who is among Scientific American’s inaugural cohort of Young American Scientists honorees. Costa shares how being surprised by experiments has led him to new ways of thinking about learning in the brain ... Show More

Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - Why Some Dementia Experts Are Wary". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_ ... Show More

<p>The diagnostic paradigm for Alzheimer&apos;s disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This pod ... Show More

<p>For over 100 years we’ve had a similar approach to understanding Alzheimer’s disease which hasn’t produced many benefits. Perhaps it’s time to cast the net more broadly?</p> 

<p>Clinical trials in Alzheimer's disease frequently include the measurement of risk genes (i.e., the APOE e4 allele), and advancements in direct-to-consumer genetic testing (e.g., 23andMe) have made these biological data widely available to the public.  Is it helpful or harmful ... Show More

For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure? For more, go to http://vox.com/unexplainable It’s a great place to sign up for our newsletter, view show ... Show More

What are Biomarkers? And why are they useful in Alzheimer's Disease Research. 

For the nearly 7 million Americans living with Alzheimer’s, progress on treatments has felt painfully slow and incremental at best…until now. Dr. Sanjay Gupta traveled the country meeting people who have slowed, prevented, and in some cases even reversed the spread of Alzheimer’s ... Show More